関連する実験動画
Updated: Jun 22, 2026

11:22
The α-test: Rapid Cell-free CD4 Enumeration Using Whole Saliva
Published on: May 16, 2012
甲状腺機能第一線検査としてタイロトロピン濃度の使用における落とし穴
Lancet (London, England)
|April 11, 2001
まとめ
甲状腺機能検査では,タイロトロピンのみを使用すると,下垂体関節症が見逃されることがあります. 56,000件の検査でタイロトロピンとチロキシンの測定を組み合わせたところ,15件の疑われない症例が明らかになり,この状態は診断不足であることを示唆しています.
科学分野:
- エンドクリノロジー エンドクリノロジー
- クリニカル診断士
背景:
- タイロトロピン (TSH) は,プライマリな甲状腺機能検査です.
- TSH単独では,下垂体位症を検出できない可能性があります.
- 甲状腺下垂体症の診断には,甲状腺の総合的な評価が必要です.
関連する概念動画
Myasthenia Gravis: Diagnostic Tests
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
Serum Laboratory Studies, Stool Test, Breath Test
Gastrointestinal (GI) diagnostic studies are pivotal in confirming, ruling out, diagnosing, or staging various diseases, including cancers. Following diagnosis, allocating time for discussions with the patient and providing informational resources is crucial. Diagnostic assessments of the GI tract often occur in outpatient settings like endoscopy suites or GI labs. Preparation for these tests may include dietary restrictions, fasting, liquid bowel preparations, laxatives, enemas, and the...
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...

